Literature DB >> 6210637

Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis.

R Turcotte, S Lemieux.   

Abstract

Spleen cells from Mycobacterium bovis BCG-infected C57B1/6 mice when cultured in vitro for 72 h elicited soluble suppressor mediators capable of nonspecifically suppressing the mitogen-induced blastogenesis of normal splenocytes. Maximal production of suppressor mediators occurred during the first 24 h in culture, and their production ceased after 72 h. Attempts to isolate the mediators from fresh nonincubated splenocytes failed. After incubation, a strong residual suppressive activity was constantly detected in cell preparations used for production of suppressor factors. Supernatants prepared from cultures of spleen cells of mice infected 14 days earlier possessed higher suppressive activity than did those obtained 28 days after infection. In contrast, the residual cellular suppressive activity increased during the course of the infection. Although the activity of soluble factors was not inhibited, the residual activity of incubated cells was highly depressed by the presence of mouse erythrocytes in the cultures. Thus, the incubated cells appear to act through a direct cell-to-cell contact with the mitogen-responding cells. Finally, the results of depletion experiments suggest that the two populations of BCG-induced suppressor cells, namely, T lymphocytes and macrophage-like cells, are able to elicit suppressor mediators and to retain thereafter suppressive activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6210637      PMCID: PMC351213          DOI: 10.1128/iai.36.1.263-270.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Biochemical characterization of a factor released by macrophages.

Authors:  H G Opitz; D Niethammer; R C Jackson; H Lemke; R Huget; H D Flad
Journal:  Cell Immunol       Date:  1975-07       Impact factor: 4.868

2.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  Macrophage regulation of mitogen-induced blastogenesis. I. Demonstration of inhibitory cells in the spleens and peritoneal exudates of mice.

Authors:  L G Baird; A M Kaplan
Journal:  Cell Immunol       Date:  1977-01       Impact factor: 4.868

4.  Preparation and properties of cloning inhibitory factor. II. Factors affecting its production and assay.

Authors:  R S Holzman; F T Valentine; H S Lawrence
Journal:  Cell Immunol       Date:  1973-08       Impact factor: 4.868

5.  Culture conditions affecting induction and release of lymphocyte produced proliferation inhibitory factor (PIF).

Authors:  A M Badger; S R Cooperband; J A Green
Journal:  Cell Immunol       Date:  1973-07       Impact factor: 4.868

6.  Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction.

Authors:  G A Granger; W P Kolb
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

7.  Regulatory substances produced by lymphocytes. V. Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes.

Authors:  Y Namba; B V Jegasothy; B H Waksman
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

8.  Contrasting effects of BCG on spleen and lymph node antibody responses in nude and normal mice.

Authors:  B H Doft; B Merchant; L Johannessen; S D Chaparas; N A Sher
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

Authors:  H Kirchner; A V Muchmore; T M Chused; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  An inhibitor of cell proliferation released by cultures of macrophages.

Authors:  J Calderon; R T Williams; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

View more
  14 in total

1.  The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.

Authors:  T Shimizu; C Sano; H Tomioka
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Patterns of IL-2 production and utilization in mice heavily infected with Mycobacterium bovis BCG reflect the phase of protective immunity being expressed.

Authors:  E S Miller; I M Orme
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

3.  Mechanisms underlying the depressed production of interleukin-2 in spleen and lymph node cell cultures of mice infected with Mycobacterium bovis BCG.

Authors:  R Turcotte; D Legault
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

4.  Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.

Authors:  L Mellow; E Sabbadini
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

Review 5.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

6.  Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Comparative studies on the roles of mediator molecules in expression of the suppressor activity of Mycobacterium avium complex-induced immunosuppressive macrophages against T cell and B cell mitogenic responses.

Authors:  S Cai; T Shimizu; H Tomioka
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

9.  Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

Authors:  W H de Jong; P A Steerenberg; J G Kreeftenberg; R H Tiesjema; W Kruizinga; L M van Noorle Jansen; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.